203 related articles for article (PubMed ID: 12530007)
1. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells.
Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK
Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007
[TBL] [Abstract][Full Text] [Related]
2. The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density.
Nikitovic D; Tsatsakis AM; Karamanos NK; Tzanakakis GN
Anticancer Res; 2003; 23(1A):459-64. PubMed ID: 12680249
[TBL] [Abstract][Full Text] [Related]
3. IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways.
Mitropoulou TN; Theocharis AD; Nikitovic D; Karamanos NK; Tzanakakis GN
Biochimie; 2004; 86(4-5):251-9. PubMed ID: 15194227
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine kinase and estrogen receptor-dependent pathways regulate the synthesis and distribution of glycosaminoglycans/proteoglycans produced by two human colon cancer cell lines.
Chatzinikolaou G; Nikitovic D; Stathopoulos EN; Velegrakis GA; Karamanos NK; Tzanakakis GN
Anticancer Res; 2007; 27(6B):4101-6. PubMed ID: 18225578
[TBL] [Abstract][Full Text] [Related]
5. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
He FJ; Wang J; Niu JZ; Wang JF
Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
[TBL] [Abstract][Full Text] [Related]
6. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis.
Shao ZM; Alpaugh ML; Fontana JA; Barsky SH
J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
8. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
9. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
10. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines.
Nakagawa H; Yamamoto D; Kiyozuka Y; Tsuta K; Uemura Y; Hioki K; Tsutsui Y; Tsubura A
J Cancer Res Clin Oncol; 2000 Aug; 126(8):448-54. PubMed ID: 10961387
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-binding affinity and cytotoxic activity of three new estrogen-nitrosourea conjugates in human breast cancer cell lines in vitro.
Lam HY; Ng PK; Goldenberg GJ; Wong CM
Cancer Treat Rep; 1987 Oct; 71(10):901-6. PubMed ID: 3652053
[TBL] [Abstract][Full Text] [Related]
12. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
13. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
Chen AC; Guo X; Derguini F; Gudas LJ
Cancer Res; 1997 Oct; 57(20):4642-51. PubMed ID: 9377581
[TBL] [Abstract][Full Text] [Related]
14. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
Gao HD; Sun JZ; Bi DS; Ma R
Ai Zheng; 2003 Apr; 22(4):376-9. PubMed ID: 12703992
[TBL] [Abstract][Full Text] [Related]
15. [Genistein induced apoptosis in MCF-7 and T47D cells].
Yu Z; Zhang L; Wu D
Wei Sheng Yan Jiu; 2003 Mar; 32(2):125-7. PubMed ID: 12793002
[TBL] [Abstract][Full Text] [Related]
16. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.
Brama M; Basciani S; Cherubini S; Mariani S; Migliaccio S; Arizzi M; Rosano G; Spera G; Gnessi L
Endocr Relat Cancer; 2007 Mar; 14(1):61-72. PubMed ID: 17395975
[TBL] [Abstract][Full Text] [Related]
19. [Expression of estrogen receptor in different breast cancer cell lines transfected with estrogen receptor plasmid HEGO5 mediated by FuGENE6].
Tao DD; Jiang M; Feng YD; Wu JH; Gong JP
Ai Zheng; 2004 Oct; 23(10):1166-70. PubMed ID: 15473928
[TBL] [Abstract][Full Text] [Related]
20. Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein.
Hoffman R
Biochem Biophys Res Commun; 1995 Jun; 211(2):600-6. PubMed ID: 7794275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
